Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database

Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database

Standard trastuzumab therapy can reduce the risk of early recurrence of HER2-positive breast cancer. However, trastuzumab-induced cardiac dysfunction may force the discontinuation of adjuvant trastuzumab therapy. Incidentally, there are still unclear whether or not trastuzumab treatment should be co...

Full description

Saved in:
Bibliographic Details
Main Authors: Keiko Miyazato, Hiroshi Ohtsu, Akihiko Shimomura, Naohiro Yonemoto, Chikako Shimizu, Kazuhiro Sase, Shinichiro Ueda
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Breast
Subjects:
Breast neoplasm
Trastuzumab
Heart disease
Propensity score
Japan
Mortality
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977624002029
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items